AKT1 and diabetic kidney disease: In the conditions of diabetic nephropathy and lipopolysaccharide-induced acute kidney injury, enhancing autophagy with some therapeutics through inhibition of the PI3K/AKT/mTOR pathway ameliorates kidney function [47,48].